Treatment, Medication & Supplement Directory
A comprehensive encyclopedia of medicines, chemotherapy protocols, targeted and immune therapies, supplements, Chinese herbal formulas, Traditional Chinese Veterinary Medicine (TCVM) approaches, and supportive-care options used or discussed in canine and feline tumor care. Directory entries explain what each option is, where it may fit, its evidence and safety boundaries, and what to discuss with a veterinarian; they are references, not individualized prescriptions or rankings.
Multimodal Pain Management in Canine Cancer Care
Multimodal pain management combines approaches that act at different points in the pain pathway and addresses both the tumor and its functional consequences. A plan may include prescriptions,…
Read more
Omega-3 Fatty Acid Support: Product, Dose, and Evidence Questions
Omega-3 products are nutritional supplements, not cancer treatments. EPA and DHA content, total calories, oxidation control, formulation, and quality vary widely, and evidence from one condition or diet…
Read more
Medicinal Mushroom Extracts: Product-Specific Oncology Evidence
Mushroom products differ by species, extracted fraction, standardization, contaminants, and evidence; the word mushroom does not identify a tested intervention.
Read moreTurmeric and Curcumin: Bioavailability, Interaction, and Evidence Limits
Turmeric and curcumin products vary in extract, concentration, absorption enhancers, and purity, while robust canine cancer outcome evidence is lacking.
Read more
Yunnan Baiyao-Type Hemostasis Discussion: Preclinical Evidence Is Not Bleeding Control
Yunnan Baiyao is used anecdotally in veterinary bleeding plans, but formulation opacity and limited clinical evidence do not support relying on it to prevent or stop tumor hemorrhage.
Read moreProbiotics and Synbiotics During Cancer Treatment: Strain-Specific Evidence
Probiotic effects are strain-, combination-, product-, storage-, and condition-specific, and immune compromise changes the safety conversation.
Read more
Named profile Apocaps CX: Canine Nutraceutical Product ProfileRepresentative category illustration – no product packaging is shown.Apocaps CX: Canine Nutraceutical Product Profile
Apocaps CX is a named branded product for Dogs; manufacturer positioning must be kept separate from independent clinical evidence.
Read moreNamed profile I’m-Yunity PSP: Canine Product ProfileRepresentative category illustration – no product packaging is shown.I’m-Yunity PSP: Canine Product Profile
I'm-Yunity is a named branded product for Dogs; manufacturer positioning must be kept separate from independent clinical evidence.
Read more
Named profile Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence ProfileRepresentative category illustration – no product packaging is shown.Gilvetmab: Canine PD-1 Immunotherapy and Conditional-Licence Profile
gilvetmab is covered as caninized anti-pd-1 monoclonal antibody immune-checkpoint inhibitor, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Oncept IL-2: Feline Fibrosarcoma Immunotherapy and EU Label ProfileRepresentative category illustration – no product packaging is shown.Oncept IL-2: Feline Fibrosarcoma Immunotherapy and EU Label Profile
feline interleukin-2 recombinant canarypox virus (vCP1338) is covered as veterinary biologic immunotherapy used with surgery and radiotherapy, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a…
Read more
Named profile Prednisolone in Feline and Canine Oncology: Uses and Safety BoundariesRepresentative category illustration – no product packaging is shown.Prednisolone in Feline and Canine Oncology: Uses and Safety Boundaries
prednisolone is covered as glucocorticoid with lympholytic, anti-inflammatory and supportive-care roles, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read moreNamed profile Piroxicam in Veterinary Oncology: NSAID Evidence and Interaction SafetyRepresentative category illustration – no product packaging is shown.Piroxicam in Veterinary Oncology: NSAID Evidence and Interaction Safety
piroxicam is covered as nonsteroidal anti-inflammatory drug used extra-label in selected veterinary oncology contexts, with species, evidence, regulatory, safety, interaction and monitoring boundaries for a veterinarian-led decision.
Read more